Austin Radiological Association Nuclear Medicine Procedure SPHINCTER OF ODDI STUDY (Tc-99m-Mebrofenin)

Similar documents
TRA Medical Imaging BILIARY SCAN Protocols

Austin Radiological Association Nuclear Medicine Procedure WHITE BLOOD CELL MIGRATION STUDY (In-111-WBCs, Tc-99m-HMPAO-WBCs)

Austin Radiological Association Nuclear Medicine Procedure BONE MINERAL STUDY (Tc-99m-MDP, Tc-99m-HMDP)

Austin Radiological Association Nuclear Medicine Procedure THYROID UPTAKE MEASUREMENT (I-123 or I-131 as Sodium Iodide)

Austin Radiological Association Nuclear Medicine Procedure PROSTATE CANCER STUDY (In-111-Capromab Pendetide [ProstaScint ])

Austin Radiological Association Nuclear Medicine Procedure GASTRIC EMPTYING STUDY (Tc-99m-Sulfur Colloid in Egg)

Austin Radiological Association Nuclear Medicine Procedure LYMPHOSCINTIGRAPHY (Tc-99m-Sulfur Colloid [Filtered])

Liver Scan Biliary with Ejection Fraction Measurement

Division of Nuclear Medicine Procedure / Protocol University Hospital and The American Center

Hepatocellular Dysfunction

SUMMARY OF PRODUCT CHARACTERISTICS. for. BRIDATEC, kit for radiopharmaceutical preparation

Austin Radiological Association Nuclear Medicine Procedure THERAPY FOR THYROID CANCER (I-131 as Sodium Iodide)

Austin Radiological Association Ga-68 NETSPOT (Ga-68 dotatate)

Medford Radiology Group. Guideline: NM.HEPATOBILIARY Effective Date: 09/16/2016 Last Revision Date: 09/16/2016 HEPATOBILIARY SCAN.

Palliative treatment of bone metastases with samarium-153

Austin Radiological Association Nuclear Medicine Procedure PET SODIUM FLUORIDE BONE SCAN (F-18 NaF)

Sphincter of Oddi spasm (SOS) is a rare disorder whose diagnosis is a great clinical challenge.

PHYSICAL CHARACTERISTICS

Nuclear medicine in gastrointestinal system. Assoc. prof. V. Marković, MD, PhD Assoc. prof. A. Punda, MD, PhD A. Barić, MD, nucl. med. spec.

Detection of abscesses and infection in soft tissues, particularly in patients without localizing findings.

Tc-99m Sestamibi/Tetrofosmin Stress-Rest Myocardial Perfusion Scintigraphy

Nuclear medicine in renal scarring

TABLE 1 Principal Radiation Emission Data Radiation Mean % per Disintegration Mean Energy (kev) Gamma

Austin Radiological Association BRAIN AMYLOID STUDY (F-18-Florbetapir)

Gastrointestinal tract

Biliary tree dilation - and now what?

weighing risks against benefits ALARA principle appropriate activities (radiopharmaceutical doses)

Congenital Pediatric Anomalies: A Collection of Abdominal Scintigraphy Findings: An Imaging Atlas

GASTRIC EMPTYING STUDY (SOLID)

Dual-Tracer Gated Myocardial Scintigraphy

THYROID IMAGING STUDY (Tc-99m as Sodium Pertechnetate)

Nuclear Medicine - Hepatobiliary

Brain Perfusion SPECT

Mft ] ~;;I~ [I) I~ t?l3 ilr!f S; [,j ~ M

MR imaging of primary sclerosing cholangitis (PSC) using the hepatobiliary specific contrast agent Gd-EOB-DTPA

Paediatrics. John Buscombe

Scintigraphy versus manometry in patients with suspected biliary sphincter of Oddi dysfunction

Current Management of Biliary Atresia. Janeen Jordan, MD PGY5 Surgery Grand Rounds November 19, 2007

Abdomen and Retroperitoneum Ultrasound Protocols

RENAL SCINTIGRAPHY IN THE 21 st CENTURY

R: March, E D T P A. Kit for the Preparation of Technetium Tc 99m Pentetate Injection. DIAGNOSTIC - For Intravenous Use

Is a field of radiology that uses unsealed radiation for diagnostic or therapeutic reasons Is a method of physiologic imaging, very different than

Scintigraphy (Nuclear Medicine Imaging) in Patients with Perplexing Abdominal Complaints

SPHINCTER OF ODDI DYSFUNCTION (SOD)

Nuclear medicine studies of the digestiv system. Zámbó Katalin Department of Nuclear Medicine

General Nuclear Medicine

Nuclear medicine studies of the digestiv system. Zámbó Katalin Department of Nuclear Medicine

Anatomical and Functional MRI of the Pancreas

Austin Radiological Association TUMOR GLUCOSE METABOLISM STUDY (F-18-Fluorodeoxyglucose)

Does Sphincter of Oddi Dysfunction Even Exist Anymore?

Molecular Breast Imaging: History and Recent Developments

Click Here to Continue. Click Here to Return to Table of Contents

INTRACAVITARY THERAPY FOR FLUID OR NEOPLASM (P-32 as Chromic Phosphate Colloid)

Morphine-Modified Hepatobiliary Scanning Protocol for the Diagnosis of Acute Cholecystitis

Localization of Gastrointestinal Bleeding by Cinematic 99m Tc Labeled Red Blood Cell Scan

GALLIUM CITRATE Ga 67 INJECTION

GLUCEPTATE. Technetium Tc 99m Gluceptate Kit DIAGNOSTIC DESCRIPTION

Physics of MBI (~10 slides)

OTHER NON-CARDIAC USES OF Tc-99m CARDIAC AGENTS Tc-99m Sestamibi for parathyroid imaging, breast tumor imaging, and imaging of other malignant tumors.

DRUG ELIMINATION II BILIARY EXCRETION MAMMARY, SALIVARY AND PULMONARY EXCRETION

Click Here to Continue. Click Here to Return to Table of Contents

Hepatobiliary Scintigraphy in Patients with Bile Leaks

1. OVERVIEW 2. RADIOPHARMACEUTICAL UTILIZED

Facilitating Lu 177 Personalized Dosimetry for Neuroendocrine Tumours CANM 2017

4/9/2018 OBJECTIVES PANCREAOTO BILIARY ULTRASOUND: BEYOND CHOLECYSTITIS

Division of Nuclear Medicine Procedure / Protocol University Hospital and The American Center

Abdominal ultrasound:

Pediatric Hepatobiliary, Pancreatic & Splenic US

Radiology of hepatobiliary diseases

Primary Sclerosing Cholangitis and Cholestatic liver diseases. Ahsan M Bhatti MD, FACP Bhatti Gastroenterology Consultants

Cystic Biliary Atresia: Why Is It Important to Distinguish this from Congenital Choledochal Cyst?

Hepatobiliary Scintigraphy:

Cholangiocarcinoma (Bile Duct Cancer)

I-123 Thyroid Scintigraphy

A Snapshot on Nuclear Cardiac Imaging

State of the Art Imaging for Hepatic Malignancy: My Assignment

Sodium Iodide I 131 Solution. Click Here to Continue. Click Here to Return to Table of Contents

My Patient Has Abdominal Pain PoCUS of the Biliary Tract and the Urinary Tract

Comparison of T2-weighted MRCP before and after injection of Gd-EOB-DTPA in patients with primary sclerosing cholangitis (PSC)

Radiation Detection and Measurement

Martin Law, PhD, DABSNM, DABMP Physicist ic Radiology/QMH

Figure 2: Post-cholecystectomy biliary-like pain

MRI Abdomen Protocol Pancreas/MRCP with Contrast

CARDIAC GATED BLOOD POOL STUDY - REST (Tc-99m-Red Blood Cells)

Nuclear medicine methods in the urogenital system

Amira K. Brown, Ph.D. Molecular Imaging Branch, NIMH Bldg. 1 Rm. B3-10

Product Monograph. GE Healthcare. 370 KBq Capsules Radiodiagnostic Agent (Measurement of Bile Acid Pool Loss)

Quantitative Theranostics in Nuclear Medicine

Basics of nuclear medicine

DOWNLOAD OR READ : PRIMARY SCLEROSING CHOLANGITIS PDF EBOOK EPUB MOBI

Internal Dosimetry of Human Brain for 99m tc and 131 I Using Nuclear Imaging in Bangladesh

Optimization of a routine method for bone marrow dose estimation in

Radiation Dosimetry for CT Protocols

Nuclear Medicine Imaging of Liver, Spleen and Gallbladder

Whole-body biodistribution and radiation dosimetry estimates for the β-amyloid radioligand [ 11 C]MeS-IMPY in non-human primates

Dynamic Renal Scintigraphy

A New Washout Rate Display Method for Detection of Endocardial and Pericardial Abnormalities Using Thallium-201 SPECT

SPECT TRACERS Tl-201, Tc-99m Sestamibi, Tc-99m Tetrofosmin

Normal anatomy and anatomic variants of the biliary tree and pancreatic ductal system at MRCP - what the clinicians want to know

Transcription:

Austin Radiological Association Nuclear Medicine Procedure SPHINCTER OF ODDI STUDY (Tc-99m-Mebrofenin) Overview Indications The successively demonstrates hepatic perfusion, hepatocyte clearance, hepatic parenchymal transit, and biliary excretion as the radiopharmaceutical moves from the injection site to the intestine. A scintigraphic score is obtained from quantitative and visual criteria. Evaluation of Sphincter of Oddi dysfunction (SOD) Evaluation of the post-surgical biliary tract. Detection of bile leaks. Diagnosis of biliary atresia and other congenital anomalies of the biliary tract. Evaluation of extrahepatic biliary tract obstruction. Examination Time Routine study: 90 minutes Patient Preparation The patient should have fasted at least 4 hours No narcotic pain relievers for 6 hours prior to exam. Equipment & Energy Windows Gamma camera: Large field of view. (A dual head camera with 90 capability is optimal). Collimator: Low energy, high resolution, and parallel hole. Energy window: 15-20% window centered at 140 kev.

Radiopharmaceutical, Dose, & Technique of Administration Radiopharmaceutical: Tc-99m-Mebrofenin. Dose: 5 mci (185 MBq). Pedi dose by NACG chart. Technique of administration: Standard intravenous injection. Patient Position & Imaging Field Patient position: Supine. Imaging field: Upper abdomen, off centered to the right to include the entire liver. Acquisition Protocol Sincalide (CCK) is administered 15 minutes before radiopharmaceutical is injected. CCK is infused by hand, over 3 minutes, based on patient weight using.02 mcg/kg. Acquire one minute Dynamic frames for 60 minutes. Acquire static images in conjunction with dynamic imaging. Data Processing Display static images created during dynamic imaging. Draw ROI s and create time/activity curve to complete Sphincter of Oddi Worksheet, using Series ROI curve generic processing workflow Manual Calculation of percent Common Bile Duct (CBD) emptying: Calculate the percent CBD emptying from: A - B CBD emptying (%) = x 100% A Where: A = Peak CBD counts B = CBD counts at 60 minutes When a continuously raising curve is obtained, the 30-min value is taken as peak CBD counts. Revised 02/08/16 Sphincter of Oddi study

Method for timely correction of Data Analysis and reporting errors and notification of referring parties Data Analysis and reporting errors are reported to the interpreting physician and appropriate clinic manager for timely correction and notification of the referring physician via report addendum or STAT call if error is significant. Principle Radiation Emission Data - Tc-99m Physical half-life = 6.01 hours. Radiation Mean % per disintegration Mean energy (kev) Gamma-2 89.07 140.5 Dosimetry - Tc-99m-Trimethylbromo-IDA Organ rads/6 mci mgy/222 MBq Large intestine 2.84 28.4 Small intestine 1.79 17.9 Gallbladder wall 0.82 8.2 Ovaries 0.61 6.1 Liver 0.28 2.8 Bladder wall 0.17 1.7 Whole body 0.12 1.2 Testes 0.03 0.3 Red marrow 0.02 0.2

Austin Radiological Association SPHINCTER OF ODDI STUDY Patient Label a. Time of peak liver activity: <10 min = 0; > 10 min = 1 ------------- b. Time to first visualize biliary tree: <15 min = 0; > 15 min = 1-------------- c. Prominent tree: not = 0, prom major intra = 1, prom small intra = 2--------- d. Time to first see bowel: <15 min = 0, 15-30 min = 1, >30 = 2--------------- e. CBD emptying: >50% = 0, <50% = 1, no change = 2, increased act. = 3--- f. CBD/liver activity ratio at 60 min and 15 min: 1. CBD at 60 < liver at 60 = 0 2. CBD at 60 > liver at 60, but < liver at 15 = 1 3. CBD at 60 > liver at 60, and = liver at 15 = 2 4. CBD at 60 > liver at 60, and > liver at 15 = 3 Total ---------------- % CBD Emptying = Peak CBD counts CBD counts @ 60 mins ------------------------------------------------------- X 100 Peak CBD counts Hepatobiliary scintigraphy score: normal < 5, max score = 12, higher numbers correspond to slower kinetics. A Noninvasive Test of Sphincter of Oddi Dysfunction in Postcholecystectomy Patients: The Scintigraphic Score, J Nuc Med 1992, 33:1216-1222 Revised 02/08/16 Sphincter of Oddi study

EXAM PREP: Inform patient to remain VERY still for exam no talking, no moving Evaluate your images for motion, and motion correct if necessary. This is to ensure good ROI s and time / activity curve. ROI s: Liver: Draw in the right lobe excluding visible bile ducts CBD: Draw in the lowest portion of the CBD not affected by superimposed bowel activity SCORING PARAMETERS: Score the following parameters, a-f, on worksheet: a. Time of peak liver activity. Obtained from the right lobe time / activity curve b. Time at which intrahepatic biliary tree was first visualized, determined from the static images. c. Prominence or dilatation of the biliary tree as determined from the static images as a subjective evaluation. d. Time at which bowel was first visualized as determined from the static images. e. Percent CBD emptying as calculated from the CBD curve using the equation on the worksheet. f. CBD-to-Liver ratio. This parameter is obtained from the static images by visually comparing the CBD at 60 min (CBD60) to the liver parenchyma at 60 (Liver60) and liver parenchyma at 15 min (Liver15). This ratio represents activity retained in the CBD at the end of the study. The range of the final score varies from a minimum of 0 to a maximum of 12, the higher numbers corresponding to the slower kinetics.